房静远,刘文忠,李兆申,杜亦奇,纪小龙,戈之铮,李延青,姒健敏,吕农华,吴开春,陈萦,萧树东

• 1:中华医学会消化病学分会

摘要(Abstract)：

<正>自2006年9月在上海召开的全国慢性胃炎研讨会制订了《中国慢性胃炎共识意见》[1]以来,国际上有关慢性胃炎的诊疗出现了某些新进展,慢性胃炎的分级分期评估系统(operative link for gastritis assessment,OLUA)[2,3]、欧洲《胃癌癌前状态处理共识意见》MaastrichtⅣ共识[5]提出幽门螺杆菌(H.pylori)与慢性胃炎和胃癌的关系及根除H.pylori的作用[1]、慢性胃炎内镜和病理诊断手

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 房静远,刘文忠,李兆申,杜亦奇,纪小龙,戈之铮,李延青,姒健敏,吕农华,吴开春,陈萦,萧树东

参考文献(References)：

• [1]中华医学会消化病学分会.中国慢性胃炎共识意见(2006,上海)[J].中华消化杂志,2007,27:45-49,118-120.
• [2]RuggeM,Meggio A,Pennelli G,et al.Gastritis staging inclinical practice:the OLGA staging system[J].Gut,2007,56:631-636.
• [3]Rugge M,Correa P,Di Mario F,et al.OLGA staging forgastritis:a tutorial.Dig Liver Dis,2008,40:650-658.
• [4]Dinis-Ribeiro M,Areia M,de Vries AC,et al.Management ofprecancerous conditions and lesions in the stomach(MAPS):guideline from the European Society of GastrointestinalE n d o s c o p y(E S G E),E u r o p e a n H e l i c o b a c t e r S t u d yGroup(EHSG),European Society of Pathology(ESP),and theSociedade Portuguesa de Endoscopia Digestiva(SPED)[J].Endoscopy,2012,44:74-94.
• [5]Malfertheiner P,Megraud F,O’Morain CA,et al.Managementof Helicobacter pylori infection-the MaastrichtⅣ/FlorenceConsensus Report[J].Gut,2012,61:646-664.
• [6]Sonnenberg A,Lash RH,Genta RM.A national study ofHelicobactor pylori infection in gastric biopsy specimens[J].Gastroenterology,2010,139:1894-1901.
• [7]Veldhuyzen van Zanten SJ,Pollak PT,Best LM,et al.Increasing prevalence of Helicobacter pylori infection withage:continuous risk of infection in adults rather than cohorteffect[J].J Infect Dis,1994,169:434-437.
• [8]Weck MN,Brenner H.Prevalence of chronic atrophic gastritisin different parts of the world[J].Cancer Epidemiol Biomarkersprev,2006,15:1083-1094.
• [9]Kim S,Harum K,Ito M,et al.Magnifying gastroendoscopy fordiagnosis of histologic gastritis in the gastric antrum[J].DigLiver dis,2004,36:286-291.
• [10]Kaminishi M,Oohara T,Sakai S,et al.Endoscopic Classificationof chronic gastritis based on a pilot study by the ResearchSociety for Gastritis[J].Dig Endosc,2002,14:138-151.
• [11]Areia M,Amaro P,Dinis-Ribeiro M,et al.External validationof a classification for methylene blue magnificationChromoendoscopy in premalignant gastric lesions[J].Gastrointest Endosc,2008,67:1011-1018.
• [12]Tanaka K,Toyoda H,kadowaki S,et al.Surface patternclassification by enhanced-magnification endoscopy forIdentifying early gastric cancers[J].gastrointest Endosc,2008,67:430-437.
• [13]Mouzyka S,Fedoseeva A.Chromoendoscopy with hematoxylinin the classification of gastric lesions[J].Gastric Cancer,2008,11:15-22.
• [14]Nguyen NQ,Leong RW.Current application of confocalEndomicroscopy in gastrointestinal disorders[J].GastroenterolHepatol,2008,23:1483-1491.
• [15]Tahara T,ShibataT,Nakamura M,et al.Gastric mucosal Patternby using magnifying narrow-band imaging endoscopy Clearlydistinguishes histological and serological severity of Chronicgastritis[J].Gastrointest Endosc,2009,70:246-253.
• [16]Kato M,Kaise M,Yonezawa J,et al.Magnifying endoscopyWith narrow-band imaging achieves superior accuracyin the differential diagnosis of superficial gastric lesionsidentified With white-light endoscopy:a prospective study[J].GastroIntest Endosc,2010,72:523-529.
• [17]Ezoe Y,Muto M,Horimatsu T,et al.Magnifying narrowbandimaging versus magnifying white-light imaging for thedifferential diagnosis of gastric small depressive lesions:aProspective study[J].Gastrointest Endosc,2010,71:477-484.
• [18]Kanzaki H,Uedo N,Ishihara R,et al.Comprehensive Investi-gation of areae gastricae pattern in gastric corpus usingMagnifying narrow band imaging endoscopy in patientswith Chronic atrophic fundic gastritis[J].Helicobacter,2012,17:224-231.
• [19]Alaboudy AA,Elbahrawy A,Matsumoto S,et al.Conven-tional narrow-band imaging has good correlation withHistopathological severity of Helicobacter pylori gastritis[J].Digdissci,2011,56:1127-1130.
• [20]Guo YT,Li YQ,Yu T,et al.Diagnosis of gastric intestinalMetaplasia with confocal laser endomicroscopy in vivo:aProspective study[J].Endoscopy,2008,40:547-553.
• [21]Zhang JN,Li YQ,Zhao YA,et al.Classification of gastric Pitpatterns by confocal endomicroscopy[J].Gastrointest Endosc,2008,67:843-853.
• [22]Ji R,Li YQ,Gu XM,et al.Confocal laser endomicroscopyfor diagnosis of helicobacter pylori infection:a prospectiveStudy[J].Gastroenterol Hepatol,2010,25:700-705.
• [23]Wang P,Ji R,Yu T,et al.Classification of histological Severityof helicobacter pylori-associated gastritis by confocalLaserendoicroscopy[J].World J Gastroenterol,2010,16:5203-5210.
• [24]Neumann N,Kiesslich R,Wallace MB,et al.Confocallaser Endomicroscopy:technical advances and clinicalapplications[J].Gastroenterology,2010,139:388-392.e1-2.
• [25]Sepulveda AR,Patil M.Practical approach to the pathologicdiagnosis of gastritis[J].Arch pathol Lab Med,2008,132:1586-1593
• [26]Dixon MF,Genta RM,Yardley JH,et al.Classification andgrading of gastritis.The updated Sydney System.InternationalWorkshop on the Histopathology of Gastritis,Houston1994[J].Am J Surg Pathol,1996,20:1161-1181.
• [27]Hansen R,Thomson JM,Fox JG,et al.Could Helicobacterorganisms cause inflammatory bowel disease?[J].FEMSImmunol Med Microbiol,2011,61:1-14.
• [28]Warren JR.Gastric pathology associated with Helicobacterpylori[J].Gastroenterol Clin North Am,2000,29:705-751.
• [29]Marshall BJ,Armstrong JA,McGechie DB,et al.Attempt tofulfil Koch's postulates for pyloric Campylobacter[J].Med JAust,1985,142:436-439.
• [30]Nakashima R,Nagata N,Watanabe K,et al.Histologicalfeatures of nodular gastritis and its endoscopic classification[J].J Dig Dis,2011,12:436-442.
• [31]Al-Enezi SA,Alsurayei SA,Aly NY,et al.Endoscopic nodulargastritis in dyspeptic adults:prevalence and association withHelicobacter pylori infection[J].Med Princ Pract,2010,19:40-45.
• [32]Miyamoto M,Haruma K,Yoshihara M,et al.Nodular gastritisin adults is caused by Helicobacter pylori infection[J].Dig DisSci,2003,48:968-975.
• [33]Kuipers EJ,Uyterlinde AM,Pena AS,et al.Long-term sequelaeof Helicobacter pylori gastritis[J].Lancet,1995,345:1525-1528.
• [34]Asaka M,Sugiyama T,Nobuta A,et al.Atrophic gastritis andintestinal metaplasia in Japan:results of alarge multi-Centerstudy[J].Helicobacter,2001,6:294-299.
• [35]Zeng ZR,Hu PJ,Hu S,et al.Association of interleukin 1B genepolymorphism and gastric cancers in high and low Prevalenceregionsin China[J].Gut,2003,52:1684-1689.
• [36]El-Omar EM,Carrington M,Chow WH,et al.Interleukin-1polymorphisms associated with increased risk of gastriccancer[J].Nature,2000,404:398-402.
• [37]Atherton JC.The pathogenesis of Helicobacter pyloriinducedgastro-duodenal diseases[J].Annu Rev Pathol,2006,1:63-96.
• [38]刘文忠.幽门螺杆菌感染慢性胃炎和功能性消化不良[J].中华消化杂志,2002,22:581-582.
• [39]Talley NJ,Vakil NB,Moayyedi P.American gastroenterologicalassociation technical review on the evaluation of dyspepsia[J].Gastroenterology,2005,129:1756-1780.
• [40]Sheu BS,Yang HB,Wang YL,et al.Pretreatment gastrichistology is helpful to predict the symptomatic response after H.pylori eradication in patients with nonulcer dyspepsia[J].DigDis Sci,2001,46:2700-2707.
• [41]Lan L,Yu J,Chen YL,et al.Symptom-based tendencies ofHelicobacter pylori eradication in patients with functionaldyspepsia[J].World J Gastroenterol,2011,17:3242-3247.
• [42]Zhou L,Sung JJ,Lin S,et al.A five-year follow-up studyon the pathological changes of gastric mucosa after H.pylorieradication[J].Chin Med J(Engl),2003,116:11-14.
• [43]Rokkas T,Pistiolas D,Sechopoulos P,et al.The long-termimpact of Helicobacter pylori eradication on gastric histology:a systematic review and meta-analysis[J].Helicobacter,2007,12 Suppl 2:S32-38.
• [44]Wang J,Xu L,Shi R,et al.Gastric atrophy and intestinalmetaplasia before and after Helicobacter pylori eradication:ameta-analysis[J].Digestion,2011,83:253-260.
• [45]Hojo M,Miwa H,Ohkusa T,et al.Alteration of histologicalgastritis after cure of Helicobacter pylori infection[J].AlimentPharmacol Ther,2002,16:1923-1932.
• [46]Yanaoka K,Oka M,Ohata H,et al.Eradication of Helicobacter pylori prevents cancer development in subjects with Mildgastric atrophy identified by serum pepsinogen levels[J].Int JCancer,2009,125:2697-2703.
• [47]Wong BC,Zhang L,Ma JL,et al.Effects of selective COX-2inhibitor and Helicobacter pylori eradication on Precancerousgastric lesions[J].Gut,2012,61:812-818.
• [48]Ierardi E,Monno RA,Gentile A,et al.Helicobacter heilmanniigastritis:a histological and immunohistochemical Trait[J].JClin Pathol,2001,54:774-777.
• [49]Okiyama Y,Matsuzawa K,Hidaka E,et al.Helicobacterheilmannii infection:clinical,endoscopic and histo-Pathological features in Japanese patients[J].Pathol Int,2005,55:398-404.
• [50]Morgner A,Lehn N,Andersen LP,et al.Helicobacterheilmannii-associated primary gastric low-grade MALTlymphoma:complete remission after curing the infection[J].Gastroenterology,2000,118:821-828.
• [51]李静,陈烨,周永柏,等.H.heilmannii与H.pylori相关性胃炎的对比研究[J].中华消化内镜杂志,2008,25:299-303.
• [52]Borch K,Jnsson KA,Petersson F,et al.Prevalence ofgastroduodenitis and Helicobacter pylori infction in ageneral Population sample:relations to symptomatology andlifestyle[J].Dig Dis Sci,2000,45:1322-1329.
• [53]Redéen S,Petersson F,Jonsson KA,et al.Relationship ofgastroscopic features to histological findings in gastritis andHelicobacter pylori infection in a general population sample[J].Endoscopy,2003,35:946-950.
• [54]Kinoshita Y,Chiba T,FUTURE Study Group.Characteristics ofJapanese patients with chronic gastritis and Comparison withfunctional dyspepsia defined by ROMEⅢcriteria:based onthe large-scale survey,FUTURE study[J].Intern Med,2011,50:2269-2276.
• [55]Abid S,Siddiqui S,Jafri W.Discriminant value of RomeⅢquestionnaire in dyspeptic patients[J].Saudi J Gastroenterol,2011,17:129-133.
• [56]Grassi M,Petraccia L,Mennuni G,et al.Changes,functionaldisorders,and diseases in the gastrointestinal tract Of elderly[J].Nutr Hosp,2011,26:659-668.
• [57]Pilotto A,Salles N.Helicobacter pylori infection ingeriatrics[J].Helicobacter,2002,7 Suppl 1:S56-62.
• [58]Vǎǎnǎnen H,Vauhkonen M,Helske T,et al.Nonendoscopicdiagnosis of atrophic gastritis with a blood test.Correlationbetween gastric histology and serum levels of gastrin-17 andpepsinogenⅠ:a multicentre study[J].Eur J GastroenterolHepatol,2003,15:885-891.
• [59]Wu KC,Li HT,QiaoTD,et al.Diagnosis of atrophic bodygastritis in Chinese patients by measuring serum pepsinogen[J].Chin J Dig Dis,2004,5:22-27.
• [60]曹勤,冉志华,萧树东.血清胃蛋白酶原胃泌素-17和幽门螺杆菌IgG抗体筛查萎缩性胃炎和胃癌[J].胃肠病学杂志,2006,11:388-394.
• [61]Annibale B,Negrini R,Caruana P,et al.Two-thirds of atrophicbody gastritis patients have evidence of Helicobacter Pylori infection[J].Helicobacter,2001,6:225-233.
• [62]Annibale B,Di Giulio E,Caruana P,et al.The long-termeffects of cure of Helicobacter pylori infection on patientswith atrophic body gastritis[J].Aliment Pharmacol Ther,2002,16:1723-1731.
• [63]中华医学会消化病学分会幽门螺杆菌学组/幽门螺杆菌科研协作组.第三次全国幽门螺杆菌感染若干问题共识报告(2007年8月庐山)[J].胃肠病学杂志,2008,13:42-46.
• [64]Moayyedi P,Deeks J,Talley NJ,et al.An update of theCochrane systematic review of Helicobacter pylori eradicationtherapy in nonulcer dyspepsia:resolving the discrepancybetween systematic reviews[J].Am J Gastroenterol,2003,98:2621-2626.
• [65]Mazzoleni LE,Sander GB,Francesconi CF,et al.Helicobacterpylori eradication in functional dyspepsia:HEROES trial[J].Arch Intern Med,2011,171:1929-1936.
• [66]中华医学会消化病学分会.第四次全国幽门螺杆菌感染处理共识报告[J].中华消化杂志,2012,32:655-661.
• [67]Vakil N,van Zanten SV,Kahrilas P,et al.The Montrealdefinition and classification of gastroesophageal refux disease:a global evidence-based consensus[J].Am J Gastroenterol,2006,101:1900-1920.
• [68]中华医学会消化病学分会胃肠动力学组.慢性胃炎患者消化不良症状胃动力功能及有关因素的多中心调研[J].中华消化杂志,2006,26:602-605.
• [69]Seno H,Nakase H,Chiba T.Usefulness of famotidine infunctional dyspepsia patient treatment:comparison amongprokinetic,acid suppression and antianxiety therapies[J].Aliment Pharmacol Ther,2005,21 Suppl2:S32-36.
• [70]Taylor KM,Harris AW.Itopride for functional dyspepsia[J].NEngl J Med,2006,354:2392.
• [71]Guslandi M,Ferrero S,Fusillo M.Sucralfate gel forsymptomatic chronic gastritis:multicentre comparative trialVersus sucralfate suspension[J].Ital J Gastroenterol,1994,26:442-445.
• [72]Haruma K,Ito M.Review article:clinical significance ofmucosal-protective agents:acid,infammation,carcino-genesisand rebamipide[J].Aliment Pharmacol Ther,2003,18 Suppl1:S153-159.
• [73]刘新光,贾博琦,林三仁,等.替普瑞酮对慢性浅表性胃炎疗效的临床研究[J].中华内科杂志,1996,35:12-14.
• [74]OhtaY,Kobayashi T,Imai Y,et al.Effect of gefarnate onacute gastric mucosal lesion progression in rats treated withCompound 48/80,a mast cell degranulator,in comparison withthat of teprenone[J].Biol Pharm Bull,2005,28:1424-1430.
• [75]DU YQ,Su T,Hao JY,et al.Gastro-protecting effectof gefarnate on chronic erosive gastritis with dyspepticsymptoms[J].Chin Med J(Engl),2012,125:2878-2884.
• [76]Du Y,Li Z,Zhan X,et al.Anti-inflammatory effects ofrebamipide according to Helicobacter pylori status in patientswith chronic erosive gastritis:a randomized sucralfatecontrolledmulticenter trial in China-STARS study[J].Dig Dis Sci,2008,53:2886-2895.
• [77]Pearson JP,Roberts NB.Mucosal protective effects of ecabet sodium:pepsin inhibition and interaction with mucus[J].ClinSci(Lond),2001,100:411-417.
• [78]多潘立酮临床协作组.多潘立酮及铝碳酸镁治疗胆汁反流性胃炎多中心临床观察[J].中华消化杂志,2003,23:275-278.
• [79]陈慧敏,李晓波,戈之铮.雷贝拉唑和铝碳酸镁治疗胆囊切除术后伴胆汁反流的胃炎作用比较[J].中华消化杂志,2010,30:529-534.
• [80]中国中西医结合学会消化系统疾病专业委员会.功能性消化不良的中西医结合诊疗共识意见(2010)[J].中国中西医结合杂志,2011,31:1545-1549.
• [81]上海市泌特临床协作组.复方阿嗪米特肠溶片治疗消化不良的多中心随机双盲安慰剂平行对照临床研究[J].胃肠病学杂志,2005,10:83-87.
• [82]Correa P,Haenszel W,Cuello C,et al.A model for gastriccancer epidemiology[J].Lancet,1975,2:58-60.
• [83]Correa P.A human model of gastric carcinogenesis[J].CancerRes,1988,48:3554-3560.
• [84]Correa P.Human gastric carcinogenesis:a multistep andmultifactorial process-First American Cancer Society AwardLecture on Cancer Epidemiology and Prevention[J].CancerRes,1992,52:6735-6740.
• [85]Boss GR,Seegmiller JE.Age-related physiological changesand their clinical significance[J].West J Med,1981,135:434-440.
• [86]Chooi EY,Chen HM,Miao Q,et al.Chronic atrophic gastritisis a progressive disease:analysis of medical reports FromShanghai(1985-2009)[J].Singapore Med J,2012,53:318-324.
• [87]Nomura A,Grove JS,Stemmermann GN,et al.A prospectivestudy of stomach cancer and its relation to diet,cigarettes,andalcohol consumption[J].Cancer Res,1990,50:627-631
• [88]Gao QY,Wang ZH,Hao EY,et al.A novel model might predictthe risk of chronic atrophic gastritis:a multicenter Prospectivestudy in China[J].Scand J Gastroenterol,2012,47:509-517.
• [89]D e Vr i e s A C,v a n G r i e k e n N C,L o o m a n C W,e t a l.Gastric cancer risk in patients with premalignant gastriclesions:a nationwide cohort study in the Netherlands[J].Gastroenterology,2008,134:945-952.
• [90]Sipponen P.Natural history of gastritis and its relationship topeptic ulcer disease[J].Digestion,1992,51 Suppl 1:S 70-75.
• [91]Rugge M,Genta RM.Staging and grading of chronicgastritis[J].Hum Pathol,2005,36:228-233.
• [92]Kuipers EJ,Klinkenberg-Knol EC,Vandenbroucke-Grauls CM,et al.Role of Helicobacter pylori in the pathogenesis of atrophicgastritis[J].Scand J Gastroenterol Suppl,1997,223:28-34.
• [93]Shin WG,Kim HU,Song HJ,et al.Surveillance strategy ofatrophic gastritis and intestinal metaplasia in a country with ahigh prevalence of gastric cancer[J].Dig Dis Sci,2012,57:746-752.
• [94]Si JM,Sun LM,Fan YJ,et al.Trial of a novel endoscopictattooing biopsy forceps on animal model[J].World JGastroenterol,2005,11:1859-1861.
• [95]Sun L,Si J,Chen S,et al.The establishment and clinicalappliance of technique of mucosa marking targeting biopsy[J].Hepatogast roenterology,2009,56:59-62.
• [96]You WC,Zhang L,Gail MH,et al.Gastric dysplasia andgastric cancer:Helicobacter pylori,serum vitamin C,and Otherrisk factors[J].J Natl Cancer Inst,2000,92:1607-1612.
• [97]You WC,Brown LM,Zhang L,et al.Randomized doubleblindfactorial trial of three treatments to reduce the Prevalenceof precancerous gastric lesions[J].J Natl CancerInst,2006,98:974-983.
• [98]Wong BC,Lam SK,Wong WM,et al.Helicobacter pylorieradication to prevent gastric cancer in a high-risk region ofChina:a randomized controlled trial[J].J AMA,2004,291:187-194.
• [99]Kodama M,Murakami K,Okimoto T,et al.Ten-yearprospective follow-up of histological changes at five points onthe gastric mucosa as recommended by the updated Sydneysystem after Helicobacter pylori eradication.[J]J Gastroenterol,2012,47:394-403.
• [100]Ma JL,Zhang L,Brown LM,et al.Fifteen-year effects ofHelicobacter pylori,garlic,and vitamin treatments on gastriccancer incidence and mortality[J].J Natl Cancer Inst,2012,104:488-492.
• [101]Yuan JM,Ross RK,Gao YT,et al.Prediagnostic levels ofserum micronutrients in relation to risk of gastric cancer inShanghai,China[J].Cancer Epidemiol Biomarkers Prev,2004,13:1772-1780.
• [102]Taylor PR,Qiao YL,Abnet CC,et al.Prospective study ofserum vitamin E levels and esophageal and gastric cancers[J].JNatl Cancer Inst,2003,95:1414-1416.
• [103]Jacobs EJ,Connell CJ,McCullough ML,et al.Vitamin C,vitamin E,and multivitamin supplement use and stomachCancer mortality in the Cancer Prevention StudyⅡcohort[J].Cancer Epidemiol Biomarkers Prev,2002,11:35-41.
• [104]Malila N,Taylor PR,Virtanen MJ,et al.Effects of alphato-copherol and beta-carotene supplementation on gastric cancerincidence in male smokers(ATBCStudy,Finland)[J].CancerCauses Control,2002,13:617-623.
• [105]Glade MJ.Food,nutrition,and the prevention of cancer:aglobal perspective.American Institute for Cancer Research/World Cancer Research Fund,American Institute for CancerResearch,1997[J].Nutrition,1999,15:523-526.
• [106]Lee KW,Lee HJ,Surh YJ,et al.Vitamin C and cancerchemoprevention:reappraisal[J].Am J Clin Nutr,2003,78:1074-1078.
• [107]Kim DS,Lee MS,Kim YS,et al.Effect modificationby vitamin C on the relation between gastric cancer andHelicobacter pylori[J].Eur J Epidemiol,2005,20:67-71.
• [108]Kodama K,Sumii K,Kawano M,et al.Gastric juice nitriteand vitamin C in patients with gastric cancer and atrophicgastritis:is low acidity solely responsible for cancerrisk?[J].EurJ Gastroenterol Hepatol,2003,15:987-993.
• [109]van den Brandt PA,Goldbohm RA.Nutrition in the preventionof gastrointestinal cancer[J].Best Pract Res Clin Gastroenterol,2006,20:589-603.
• [110]Verma A,Atten MJ,Attar BM,et al.Selenomethionine stimulates MAPK(ERK)phosphorylation,protein oxidation,and DNA synthesis in gastric cancer cells[J].Nutr Cancer,2004,49:184-190.
• [111]Zhang L,Blot WJ,You WC,et al.Serum micronutrients inrelation to pre-cancerous gastric lesions[J].Int J Cancer,1994,56:650-654.
• [112]Fang JY,Xiao SD,Zhu SS,et al.Relationship of plasma folicacid and status of DNA methylation in human gastric cancer[J].J Gastroenterol,1997,32:171-175.
• [113]Fenech M.The role of folic acid and Vitamin B12 in genomicstability of human cells[J].Mutat Res,2001,475:57-67.
• [114]Choi SW,Mason JB.Folate status:effects on pathways ofcolorectal carcinogenesis[J].J Nutr,2002,132:2413S-2418S.
• [115]Choi SW,Mason JB.Folate and carcinogenesis:an integratedscheme[J].J Nutr,2000,130:129-132.
• [116]Wang X,Thomas P,Xue J,et al.Folate deficiency inducesaneuploidy in human lymphocytes in vitro-evidence usingcytokinesis-blocked cells and probes specific for chromosomes17 and 21[J].Mutat Res,2004,551:167-180.
• [117]Mayne ST,Risch HA,Dubrow R,et al.Nutrient intake andrisk of subtypes of esophageal and gastric cancer[J].CancerEpidemiol Biomarkers Prev,2001,10:1055-1062.
• [118]Fang JY,Xiao SD.Folicacid,polymorphism of methylgroupmetabolism genes,and DNA methylation in relation to GIcarcinogenesis[J].J Gastroenterol,2003,38:821-829.
• [119]Xiao SD,Meng XJ,Shi Y,et al.Interventional study of highdose folic acid in gastric carcinogenesis in beagles[J].Gut,2002,50:61-64.
• [120]Zhu S,Mason J,Shi Y,et al.The effect of folic acid on thedevelopment of stomach and other gastrointestinal cancers[J].Chin Med J(Engl),2003,116:15-19.
• [121]李晓波,刘文忠,徐蔚文,等.上海地区幽门螺杆菌菌株cag致病岛基因cagAcagEcagT检出率及临床意义[J].中华消化杂志,2000,20:371-373.
• [122]韩跃华,刘文忠,朱红音,等.上海地区幽门螺杆菌菌株iceAbabA2基因型与临床的关系[J].中华消化杂志,2004,24:322-325.
• [123]Madisch A,Miehlke S,Neuber F,et al.Healing of lymphocyticgastritis after Helicobacter pylori eradication Therapy arandomized,double-blind,placebo-controlled multicentretrial[J].Aliment Pharmacol Ther,2006,23:473-479.
• [124]Santolaria Piedrafita S,Conde García R,Abascal Agorreta M,et al.Resolution of Ménétrier's disease after eradication ofHelicobacter pylori infection[J